Keidel K, Murawski C, Pantelis C, Ettinger U
Schizophr Bull. 2025; 51(Supplement_2):S64-S73.
PMID: 40037816
PMC: 11879521.
DOI: 10.1093/schbul/sbad110.
Peeters L, Wills L, Cuozzo A, Ivanich K, Turney S, Bullock L
Pharmacol Biochem Behav. 2024; 239():173752.
PMID: 38521210
PMC: 11088493.
DOI: 10.1016/j.pbb.2024.173752.
Chen X, Wang S, Shen W
Medicine (Baltimore). 2024; 103(11):e37355.
PMID: 38489734
PMC: 10939700.
DOI: 10.1097/MD.0000000000037355.
Gao Z, Xiu M, Liu J, Wu F, Zhang X
Curr Neuropharmacol. 2023; 22(10):1733-1741.
PMID: 37859307
PMC: 11284715.
DOI: 10.2174/1570159X22666231019105328.
Zheng C, Liu H, Tu W, Lin L, Xu H
Ther Adv Psychopharmacol. 2023; 13:20451253231200257.
PMID: 37781686
PMC: 10540600.
DOI: 10.1177/20451253231200257.
Reinstatement of nicotine conditioned place preference in a transgenerational model of drug abuse vulnerability in psychosis: Impact of BDNF on the saliency of drug associations.
Peeters L, Wills L, Cuozzo A, Ivanich K, Brown R
Psychopharmacology (Berl). 2023; 240(7):1453-1464.
PMID: 37160431
PMC: 10330905.
DOI: 10.1007/s00213-023-06379-7.
The Epigenetics of Psychosis: A Structured Review with Representative Loci.
Miller C
Biomedicines. 2022; 10(3).
PMID: 35327363
PMC: 8945330.
DOI: 10.3390/biomedicines10030561.
Impaired long-term outcomes of patients with schizophrenia spectrum disorder after coronary artery bypass surgery: nationwide case-control study.
Kallio M, Korkeila J, Malmberg M, Gunn J, Rautava P, Korhonen P
BJPsych Open. 2022; 8(2):e48.
PMID: 35144708
PMC: 8867870.
DOI: 10.1192/bjo.2022.10.
New concepts in the development of schizophrenia, autism spectrum disorders, and degenerative brain diseases based on chronic inflammation: A working hypothesis from continued advances in neuroscience research.
Blaylock R, Faria M
Surg Neurol Int. 2021; 12:556.
PMID: 34877042
PMC: 8645502.
DOI: 10.25259/SNI_1007_2021.
Novel disease associations with schizophrenia genetic risk revealed in ~400,000 UK Biobank participants.
Zhang R, Sjolander A, Ploner A, Lu D, Bulik C, Bergen S
Mol Psychiatry. 2021; 27(3):1448-1454.
PMID: 34799693
PMC: 9106855.
DOI: 10.1038/s41380-021-01387-5.
The side effect profile of Clozapine in real world data of three large mental health hospitals.
Iqbal E, Govind R, Romero A, Dzahini O, Broadbent M, Stewart R
PLoS One. 2020; 15(12):e0243437.
PMID: 33290433
PMC: 7723266.
DOI: 10.1371/journal.pone.0243437.
Exercise and Schizophrenia.
Bueno-Antequera J, Munguia-Izquierdo D
Adv Exp Med Biol. 2020; 1228:317-332.
PMID: 32342467
DOI: 10.1007/978-981-15-1792-1_21.
Experiences of Tobacco Use among Chinese Individuals with Schizophrenia in Community-Based Residential Settings: A Qualitative Study.
Mak Y, Chiang V, Yuen Loke A
Int J Environ Res Public Health. 2020; 17(1).
PMID: 31906522
PMC: 6981445.
DOI: 10.3390/ijerph17010321.
Pharmacological and behavioural interventions to promote smoking cessation in adults with schizophrenia and bipolar disorders: a systematic review and meta-analysis of randomised trials.
Pearsall R, Smith D, Geddes J
BMJ Open. 2019; 9(11):e027389.
PMID: 31784428
PMC: 6924825.
DOI: 10.1136/bmjopen-2018-027389.
Changes in smoking status, mental state and plasma clozapine concentration: retrospective cohort evaluation.
Qurashi I, Stephenson P, Nagaraj C, Chu S, Drake R, Couchman L
BJPsych Bull. 2019; 43(6):271-274.
PMID: 31391141
PMC: 8058886.
DOI: 10.1192/bjb.2019.50.
Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study.
McInerney S, Finnerty S, Walsh E, Spelman L, Edgar N, Hallahan B
Soc Psychiatry Psychiatr Epidemiol. 2018; 53(8):795-801.
PMID: 29704022
DOI: 10.1007/s00127-018-1520-3.
Exploring online communication about cigarette smoking among Twitter users who self-identify as having schizophrenia.
Hswen Y, Naslund J, Chandrashekar P, Siegel R, Brownstein J, Hawkins J
Psychiatry Res. 2017; 257:479-484.
PMID: 28841509
PMC: 5877400.
DOI: 10.1016/j.psychres.2017.08.002.
Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life.
Li X, An F, Ungvari G, Ng C, Chiu H, Wu P
Sci Rep. 2017; 7(1):8430.
PMID: 28814728
PMC: 5559601.
DOI: 10.1038/s41598-017-07928-9.
Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.
Tekin Uludag Y, Gulec G
Noro Psikiyatr Ars. 2017; 53(1):4-11.
PMID: 28360758
PMC: 5353236.
DOI: 10.5152/npa.2015.8827.
BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.
King D, Iwuagwu C, Cook J, Mcdonald I, Mate R, Zusi F
ACS Med Chem Lett. 2017; 8(3):366-371.
PMID: 28337332
PMC: 5346989.
DOI: 10.1021/acsmedchemlett.7b00032.